Need for a Public Health Response to the Unregulated Sales of Amanita muscaria Mushrooms
American Journal of Preventive Medicine June 10, 2024 Eric C. Leas, Nora Satybaldiyeva, Wayne Kepner et al. 10 citations
Use of psilocybin-containing mushrooms among U.S. adults rose from 11.4% in 2021 to 12.3% in 2022, making them the most commonly used hallucinogenic substance. This growing interest has spurred a commercial market for other mushrooms, including Amanita muscaria, which contains the psychoactive compounds muscimol and ibotenic acid.